The Use of Urinary Nuclear Matrix Protein 22 (NMP22) as a Diagnostic Adjunct to Urine Cytology for Monitoring of Recurrent Bladder Cancer-Institutional Experience and Review

Onal B., Han U., Yilmaz S., Koybasioglu F., Altug U.

DIAGNOSTIC CYTOPATHOLOGY, cilt.43, sa.4, ss.307-314, 2015 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 43 Sayı: 4
  • Basım Tarihi: 2015
  • Doi Numarası: 10.1002/dc.23239
  • Dergi Adı: DIAGNOSTIC CYTOPATHOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.307-314
  • Anahtar Kelimeler: NMP22, urine cytology, urothelial carcinoma bladder, recurrence, performance, TRANSITIONAL-CELL CARCINOMA, TUMOR-MARKERS, RISK, NUCLEAR-MATRIX-PROTEIN-22, SURVEILLANCE, NMP-22
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Hayır

Özet

BackgroundThis prospective study compares urine NMP22 immunoassay and cytomorphology for detecting recurrent urothelial carcinoma (UC) of the bladder and correlates between NMP22 levels and grade, multiplicity, and size of the tumor. We aimed refining the use of NMP22 test in the management of UC at our institution.